A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study.

被引：0

作者：

Zavada, Jakub ^{[1
]}

Uher, Michal ^{[2
]}

Sisol, Katarina ^{[3
]}

Forejtova, Sarka ^{[3
]}

Jarosova, Katerina ^{[3
]}

Mann, Herman F. ^{[4
,5
]}

Vencovsky, Jiri ^{[4
,6
]}

Pavelka, Karel ^{[3
]}

机构：

[1] Charles Univ Prague, Prague, Czech Republic

[2] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic

[3] Inst Rheumatol, Prague, Czech Republic

[4] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic

[5] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic

[6] Charles Univ Prague, Fac Med 1, Clin Rheumatol, Prague, Czech Republic

来源：

ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

851

引用

页码：S376 / S376

页数：1

共 4 条

[1] A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study
Zavada, Jakub
Uher, Michal
Sisol, Katarina
Forejtova, Sarka
Jarosova, Katerina
Mann, Herman
Vencovsky, Jiri
Pavelka, Karel
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) : 96 - 102
[2] A TAILORED APPROACH TO REDUCE DOSE OF ANTI-TNF DRUGS IS EQUALLY EFFECTIVE AND LESS COSTLY THAN STANDARD DOSING IN PATIENTS WITH ANKYLOSING SPONDYLITIS OVER TWO YEARS: A PROPENSITY SCORE-MATCHED COHORT STUDY
Zavada, J.
Uher, M.
Sisol, K.
Forejtova, S.
Jarosova, K.
Mann, H.
Vencovsky, J.
Pavelka, K.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 749 - 749
[3] A TAILORED APPROACH TO REDUCE DOSE OF ANTI-TNF DRUGS IS EQUALLY EFFECTIVE, BUT SUBSTANTIALLY LESS COSTLY THAN STANDARD DOSING IN PATIENTS WITH ANKYLOSING SPONDYLITIS OVER ONE YEAR: A MATCHED OBSERVATIONAL STUDY
Zavada, J.
Uher, M.
Sisol, K.
Forejtova, S.
Jarosova, K.
Mann, H.
Vencovsky, J.
Pavelka, K.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 719 - 719
[4] A Tailored Approach to Reduce Dose of TNF Inhibitors Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Rheumatoid Arthritis over One and Two Years: A Prospective Cohort Study.
Zavada, Jakub
Uher, Michal
Sisol, Katarina
Forejtova, Sarka
Jarosova, Katerina
Sedova, Liliana
Urbanova, Zuzana
Sleglova, Olga
Vencovsky, Jiri
Pavelka, Karel
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1056 - S1057

← 1 →